Genetic polymorphisms of GSTP1 and mEPHX correlate with oxidative stress markers and lung function in COPD

Biochemical and Biophysical Research Communications

Volumn 359, Issue 1, 2007, Pages 136-142

  Vibhuti, Arpana ^a,b   Arif, Ehtesham ^a,c   Deepak, Desh ^d   Singh, Bhawani ^d   Qadar Pasha, M A ^a,b,c  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b UNIVERSITY OF PUNE   (India)

^c Department of Medical Elementology and Toxicology ^*  (India)

^d DR RAM MANOHAR LOHIA HOSPITAL   (India)

Author keywords

Glutathione peroxidase; Glutathione S transferase P1; Lipid peroxidation; Lung function; Microsomal epoxide hydrolase; Polymorphism; Reduced glutathione

Indexed keywords

EPOXIDE HYDROLASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; MALONALDEHYDE;

ADULT; AIRWAY OBSTRUCTION; ALLELE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE MARKER; ENZYME BLOOD LEVEL; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; EPOXIDE HYDROLASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REACTIVE OXYGEN SPECIES; RESPIRATORY FUNCTION TESTS;

EID: 34249656273     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.076     Document Type: Article

References (31)

1. Siafakas N.M., Vermeire P., Pride N.B., Paoletti P., Gibson J., Howard P., Yernault J.C., Decramer M., Higenbottam T., Postma D.S., and On behalf of the task force. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The Eur. Resp. Soc. Task Force. Eur. Respir. J. 8 (1995) 1398-1420
2. Rahman I., and MacNee W. Oxidant antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax 51 (1996) 348-350
3. Hoidal J.R., Fox R.B., LeMarbe P.A., Perri R., and Repine J.E. Altered oxidative metabolic responses in vitro of alveolar macrophages from asymptomatic cigarette smokers. Am. Rev. Res. Dis. 123 (1981) 85-89
4. Packer L. Oxidants, antioxidant nutrients and the athlete. J. Sports Sci. 15 (1997) 353-363
5. Meister A., and Anderson M.E. Glutathione. Annu. Rev. Biochem. 52 (1983) 711-760
6. Sethi J.M., and Rochester C.L. Smoking and chronic obstructive pulmonary disease. Clin. Chest. Med. 21 (2000) 67-86
7. Snider G.L. Chronic obstructive pulmonary disease: risk factors, pathophysiology and pathogenesis. Annu. Rev. Med. 40 (1989) 411-429
8. Hayes J.D., and Strange R.C. Glutathione-S-transferase polymorphisms and their biological consequence. Pharmacology 61 (2000) 154-166
9. Cantlay A.M., Smith C.A., Wallace W.A., Yap P.L., Lamb D., and Harrison D.J. Heterogeneous expression and polymorphic genotype of glutathione-S-transferases in human lung. Thorax 49 (1994) 1010-1014
10. Johansson A.S., Stenberg G., Widersten M., and Mannervik B. Structure activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105. J. Mol. Biol. 278 (1998) 687-698
11. Ryberg D., Skaug V., Hewer A., Phillips D.H., Harries L.W., Wolf C.R., Ogreid D., Ulvik A., Vu P., and Haugen A. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18 (1997) 1285-1289
12. Watabe T., Kanai M., Isobe M., and Ozawa N. The hepatic microsomal biotransformation of delta 5-steroids to 5 alpha, 6 beta-glycols via alpha- and beta-epoxides. J. Biol. Chem. 256 (1981) 2900-2907
13. Hassett C., Aicher L., Sidhu J.S., and Omiecinski C.J. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet. 3 (1994) 421-428
14. Smith C.A., and Harrison D.J. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350 (1997) 630-633
15. Sandford A.J., Chagani T., Weir T.D., Connett J.E., Anthonisen N.R., and Pare P.D. Susceptibility genes for rapid decline of lung function in the lung health study. Am. J. Resp. Crit. Care. Med. 163 (2001) 469-473
16. American Thoracic Society. Standardization of spirometry, Am. Rev. Resp. Dis. 136 (1987) 1285-1298.
17. W Light R., Conrad S.A., and George R.B. The one best test for evaluating the effects of bronchodilator therapy. Chest 72 (1977) 512-516
18. Reis A.L. Response to Bronchodilators. Pulmonary Function Testing: Guidelines and Controversies (1982), Academics Press, New York 15-221
19. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16 (1988) 1215
20. Yim J.J., Park G.Y., Lee C.T., Kim Y.W., Han S.K., Shim Y.S., and Yoo C.G. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax 55 (2000) 121-125
21. Wright J.R., Colby H.D., and Miles P.R. Cytosolic factors which affect microsomal lipid peroxidation in lung and liver. Arch. Biochem. Biophys. 206 (1981) 296-304
22. Jollow D.J., Mitchell J.R., Zampaglione N., and Gillette J.R. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11 (1974) 151-169
23. Mohandas J., Marshall J.J., Duggin G.G., Horvath J.S., and Tiller D.J. Differential distribution of glutathione and glutathione-related enzymes in rabbit kidney, possible implications in analgesic nephropathy. Biochem. Pharmacol. 33 (1984) 1801-1807
24. Ahsan A., Ram R., Baig M.A., and Qadar Pasha M.A. ACE I allele and eNOS G allele crosstalk may have a role in chronic obstructive pulmonary disease. Clin. Biochem. 37 (2004) 1037-1040
25. Ishii T., Matsuse T., Teramoto S., Matsui H., Miyao M., Hosoi T., Takahashi H., Fukuchi Y., and Ouchi Y. Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax 54 (1999) 693-696
26. Sundberg K., Johansson A.S., Stenberg G., Widersten M., Seidel A., Mannervik B., and Jernstrom B. Differences in the catalytic efficiencies of allelic varients of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 19 (1998) 433-436
27. Repine J.E., Bast A., and Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Am. J. Resp. Crit. Care. Med. 156 (1997) 341-357
28. Dekhuijzen P.N. Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. Eur. Resp. J. 23 (2004) 629-636
29. Li X.Y., Donaldson K., Rahman I., and MacNee W. An investigation of the role of glutathione in the increased permeability induced by cigarette smoke in vivo and in vitro. Am. J. Resp. Crit. Care. Med. 149 (1994) 1518-1525
30. Rahman I., Li X.Y., Donaldson K., Harrison D.J., and MacNee W. Glutathione homeostasis in alveolar epithelial cells in vitro and lung in vivo under oxidative stress. Am. J. Physiol. 269 (1995) L285-L292
31. Harik-Khan R.I., Fleg J.L., and Wise R.A. Body mass index and the risk of COPD. Chest 121 (2002) 370-376